Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Chlorine dioxide - Tarsus Pharmaceuticals

Next Previous
Drug Profile

Chlorine dioxide - Tarsus Pharmaceuticals

Alternative Names: Aqueous chlorine dioxide solution; IRX-101

Latest Information Update: 31 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator iRenix Medical
  • Developer Tarsus Pharmaceuticals
  • Class Analgesics; Anti-infectives; Anti-inflammatories; Antiseptics; Disinfectants; Eye disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Endophthalmitis
  • Phase II/III Ocular pain

Most Recent Events

  • 09 Jul 2026 iRenix Medical has been acquired and merged into Tarsus Pharmaceuticals
  • 08 Jul 2026 Efficacy data from the phase IIb/III trial in Ocular pain release by Tarsus Pharmaceuticals
  • 31 Mar 2026 iRenix Medical completes a phase IIb/III RELIEF trial for Ocular pain in USA (Ophthalmic) (NCT05747430)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top